All news

November

2017

REPRISE trial presented as a late breaking abstract at American Society of Nephrology (ASN) Kidney Week 2017

TOKYO, JAPAN
November 4, 2017

Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced detailed results from the Phase 3 REPRISE trial of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD). Trial results showed that tolvaptan showed greater reduction on the primary endpoint, the rate of change in estimated glomerular filtration rate (eGFR) compared to placebo.

Read More
November

2017

Health Canada issues a Notice of Compliance for ABILIFY MAINTENA, approving a new indication for the maintenance monotherapy treatment of bipolar I disorder in adult patients.

Montreal, Quebec
November 2, 2017

Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for ABILIFY MAINTENA (aripiprazole for prolonged release injectable suspension), approving a new indication for the maintenance monotherapy treatment of bipolar I disorder in adult patients.

Read More
February

2017

Health Canada Approves Otsuka and Lundbeck’s REXULTI™ (brexpiprazole) as a Treatment for Schizophrenia in Adults

Montreal, Quebec
February 16, 2017

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for REXULTI™ (brexpiprazole) for the treatment of schizophrenia in adults. REXULTI™ was discovered by Otsuka and co-developed with Lundbeck. It will be co-marketed by the two companies and is expected to become commercially available in Canada this spring.

Read More
June

2015

Now Available in Canada: First-ever treatment for adults living with a life-threatening kidney disease (ADPKD)

Montreal, Quebec
June 5, 2015
Read More
Other Links

News Room
About Us

Other Sites

US Site
JP Site
EU Site

 

Our Products

ABILIFY
ABILIFY MAINTENA
BUSULFEX
JINARC
SAMSCA
REXULTI

Contact Us

1 888 997-9017
514 332-3001

Email

Med Info & Drug Safety

Location

2250 Alfred-Nobel Boulevard,
St-Laurent, Quebec,
Suite 301
H4S 2C9

Copyright Otsuka 2018. All rights reserved.
The information contained on this website is only intended for use by Canadians.